Meta-Analysis of Breast Cancer Risk in Levonorgestrel-Releasing Intrauterine System Users
- 3 April 2021
- journal article
- review article
- Published by Elsevier BV in Clinical Breast Cancer
- Vol. 21 (6), 497-508
- https://doi.org/10.1016/j.clbc.2021.03.013
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A Re-Analysis of the Cochrane Library Data: The Dangers of Unobserved Heterogeneity in Meta-AnalysesPLOS ONE, 2013
- Hormone Action in the Mammary GlandCold Spring Harbor Perspectives in Biology, 2010
- Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system: Long-term follow-up of a randomised control trialGynecologic Oncology, 2009
- A case‐control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as wellInternational Journal of Cancer, 2009
- Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine systemPatient Preference and Adherence, 2008
- Use of the Levonorgestrel-Releasing Intrauterine System and Breast CancerObstetrics & Gynecology, 2005
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Quantifying heterogeneity in a meta-analysisStatistics in Medicine, 2002
- A Risk-Benefit Assessment of the Levonorgestrel-Releasing Intrauterine SystemDrug Safety, 1996